3 August 2015Insurance

A firm hand on innovation

The unpredictability of the pharmaceutical and life sciences sector, given its infrequent nature and reliance on innovation, can result in devastating claims for insurers. However, insurers must continue to strive to smooth out the volatility and make these risks more stable.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Arch expands Middle East war coverage as conflict drives price surge

3 August 2026 Select prices have gone to multiples of what they had been pre-crisis, CEO says.

Commercial property rates will continue to soften throughout 2026, says Baldwin Group

3 August 2026 Casualty heads in other direction; class action defence spending to hit $5bn this year.

Japan Kumamoto earthquake insured losses could reach $2.1bn: Verisk

3 August 2026 Ground shaking drives losses, manufacturing disruptions add to event’s impact.

More articles

Arch expands Middle East war coverage as conflict drives price surge

Commercial property rates will continue to soften throughout 2026, says Baldwin Group

Japan Kumamoto earthquake insured losses could reach $2.1bn: Verisk

mea Platform hires former Swiss Re COO to lead EMEA strategic accounts

TWIA lines up Gallagher Re consecutive reinsurance broking term

Ageas exits 25-year Malaysia partnership in billion-dollar deal

Westfield Specialty lures AIG director to expand Nordic footprint

Gallagher Re appoints APAC facultative leader from Guy Carpenter

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze